T cell Bim levels reflect responses to anti-PD-1 cancer therapy.
Dronca RS, Liu X, Harrington SM, Chen L, Cao S, Kottschade LA, McWilliams RR, Block MS, Nevala WK, Thompson MA, Mansfield AS, Park SS, Markovic SN, Dong H.
Dronca RS, et al. Among authors: block ms.
JCI Insight. 2016 May 5;1(6):e86014. doi: 10.1172/jci.insight.86014.
JCI Insight. 2016.
PMID: 27182556
Free PMC article.